DonorConnect, InVita Healthcare Technologies, and Specialist Direct have collaborated to automate diagnostic test reporting for organ donation.

The partners have launched a new interoperability solution for organ evaluation.

The new telepathology interface is expected to save critical hours and strengthen patient safety. The advanced data exchange approach eliminates the need for manual retrieval and transcription of biopsy results for organ procurement organisations (OPOs).

Additionally, it ensures real-time and secure delivery of results and source file attachments directly into the iTransplant System, InVita’s electronic donor management platform.

DonorConnect chief operating officer Chuck Zollinger said: “At DonorConnect, we are thrilled to announce our collaboration with InVita Healthcare Technologies and Specialist Direct in developing a groundbreaking interoperability solution for organ evaluation.

“This collaboration will enhance the efficiency and effectiveness of delivering organ biopsy information to transplant decision-makers, ultimately saving more lives through transplantation.”

According to InVita, this interoperability enhances the efficiency of the organ allocation and recovery process.

It instantly delivers kidney and liver biopsy results to DonorConnect’s iTransplant System along with automated result notifications.

Furthermore, it ensures that Transplant Centers receive immediate and reliable information crucial for evaluating and accepting organ donation for their patients.

InVita CEO Todd Collins said: “At InVita we continuously seek to provide modern technological innovations that improve the donation process and ensure patient safety for transplant programs and their patients across the country.

“We’re proud to launch this new interface with innovative OPO partners like DonorConnect to optimise the critical organ evaluation process.”

Specialist Direct’s SDI Cloud transplant technology facilitates the seamless sharing of diagnostic results among OPOs and transplant hospitals, optimising the organ recovery process.

Special Direct founder and CEO Scott Rombach said: “We’re thrilled to collaborate with industry leaders InVita and DonorConnect on this mission-critical iTransplant integration initiative.

“Beginning with telepathology results, this interface will significantly improve operational efficiencies for the transplant ecosystem from both a speed and accuracy perspective.”